Detalhe da pesquisa
1.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494698
2.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795845
3.
Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone.
Haematologica
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426294
4.
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1D): e240001, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244272
5.
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders.
Eur J Haematol
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38804098
6.
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Int J Cancer
; 152(2): 239-248, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082445
7.
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
Cancer
; 129(3): 385-392, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413412
8.
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Blood
; 137(26): 3616-3628, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763699
9.
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(1): 67-81, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652935
10.
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(12): 1281-1301, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081133
11.
Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody.
Eur J Haematol
; 111(2): 318-321, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209032
12.
Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 98(2): 251-263, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309982
13.
Percutaneous Cryoablation of Plasmacytomas: Oncologic Effectiveness and Adverse Events.
J Vasc Interv Radiol
; 34(8): 1303-1310, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100197
14.
Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma.
Future Oncol
; 19(13): 887-895, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212642
15.
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple Myeloma.
J Natl Compr Canc Netw
; 20(1): 91-95, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991076
16.
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
J Natl Compr Canc Netw
; 20(1): 8-19, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991075
17.
Chimeric antigen receptor T-cells, bispecific antibodies, and antibody-drug conjugates for multiple myeloma: An update.
Am J Hematol
; 97(1): 99-118, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661922
18.
Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma.
Am J Hematol
; 97(7): 895-902, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35481878
19.
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
Am J Hematol
; 97(2): 209-215, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34822175
20.
Prognostic significance of acquired 1q22 gain in multiple myeloma.
Am J Hematol
; 97(1): 52-59, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710241